The earliest randomized studies of mRNA vaccines revealed several intriguing results, including an exponential rate of early infection following the first injection compared to placebo, reports The Epoch Times.
In a recent research paper from Sfera (Patton State Hospital, US) et al, the characterization of pathological syncytia or fusion between immune cells is described: “The LNP technology, to put it simply, mimics viral envelopes with externalized phosphatidylserine (ePS), a universal “eat me” signal, that directs immune cells to engulf the particle.
However, as ePS is also a potential “fuse me” signal, LNP may inadvertently facilitate the formation of pathological syncytia. Moreover, ePS may activate a disintegrin and metalloprotease 10 and 17 (ADAM10) (ADAM 17), master regulators of syncytia formation, contributing further to the unintended consequence of cell-cell fusion…
As mRNA vaccines are based on pre-fusion epitopes, the fusion pathology may be undeterred, allowing viral infection by syncytia formation to continue unabated. This is significant, as it could account for the reoccurrence of COVID-19symptoms in fully vaccinated individuals.”
The scientists note that SARS-CoV-2 uses more than simply the ACE2 receptor to enter the fused cells and that vaccine developers erred by ignoring this prospect. The selection of lipid nanoparticles and polyethylene glycol, which enable penetration into organs where spike protein will trigger inflammation and immune system modulation, further complicates the situation.
Sfera also considers pregnancy: “Several studies demonstrated that SARS-CoV-2 can activate HERV-W, an ancestral gene that encodes for the physiological placental fusogen syncytin-1 responsible for the merger of trophoblasts during the early pregnancy. This suggests that the reproductive post-vaccine events may be triggered by the furin cleavage site pathology.” In this particular demographic, such processes could take place in the gravid uterus, increasing the clotting and bleeding risks of ill-advised immunization.
- pathologic syncytia formation,
- use of lipid nanoparticles with PEG,
- failure to consider SARS-CoV-2 could use alternative points of cell entry other than ACE2 (metalloprotease pathway, antibody dependent enhancement, cell penetrating peptides, viroporins).
Virologists and immunologists will be cleaning up the wreckage of a disastrous vaccine campaign that has put so many at risk for more SARS-CoV-2 infections and progressive consequences over the ensuing months and years, with billions of individuals hurried into indiscriminate mRNA immunization.
It is hard to believe, but the CDC is actually recommending that everyone get a booster every two months. Why is that? Because the CDC wants everyone to think that this is how long people are “protected” after injection.The study conclusion:
The mRNA vaccines were approved on an emergency basis to combat COVID-19 pandemic. These vaccines also represent the first administration of LNPs at large scale. Taken together, they constitute milestones in the development of a novel and much promising therapeutics delivery field. Having said that, at the time of the emergency approval, the S2 viral antigen was insufficiently studied, and the FCS-mediated fusion pathology was mostly unknown. These aspects are now starting to attract attention, in an effort to best understand the underlying cellular mechanisms, pathways and potential unintended consequences.
The Pfizer and Moderna vaccines elicit powerful neutralizing antibodies against the RBS located on S1 protein and block viral entry by endocytosis. However, the S2-dependent metalloprotease pathway and other potential entry portals may not be adequately addressed by these therapeutics. Residual COVID-19 symptoms, often conceptualized as vaccine adverse effects, could be caused by FCS-mediated pathology.ADAM inhibitors and/or Omicron convalescent sera may effectively eradicate the SARS-CoV-2 virus by inhibiting metalloprotease pathway.
SOURCE – GREAT GAME INDIAhttps://www.gospanews.net/en/2022/12/22/higher-risk-of-covid-19-infection-among-vaccinated-cleveland-paper-explains-covid-breakthrough-killer-warning-by-cdc-deaths-data-and-israel-study/